...

Rodrigues: Would you begin by telling us about your background and training and what led you into a career in nursing?

...

Addendum: August 1994 
Baird: The HPMPC study was completed and found not to be very effective in preventing the development of CMV disease. Currently I am just finishing a study of a new antibiotic called Levofloxacin that will be released for the treatment of multi-drug resistant tuberculosis. In addition I am working on a study to evaluate long-term survivors, also known as long-term nonprogressors. The goal is to see if there is something special about these persons that can be identified and ultimately used to help other HIV-infected persons.